Literature DB >> 16202783

Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening.

Rebecca L Koscik1, HuiChuan J Lai, Anita Laxova, Kathleen M Zaremba, Michael R Kosorok, Jeff A Douglas, Michael J Rock, Mark L Splaingard, Philip M Farrell.   

Abstract

OBJECTIVE: To evaluate whether early diagnosis of cystic fibrosis (CF) through newborn screening (NBS) and early vitamin E status are associated with cognitive function. STUDY
DESIGN: We assessed cognitive function for 71 children without meconium ileus (ages 7.3-16.9 years) enrolled in the screened (S) or control (C) group of the Wisconsin CF Neonatal Screening Project. The Test of Cognitive Skills, 2nd edition generated the cognitive skills index (CSI; mean = 100, SD = 16). Vitamin E deficiency at diagnosis was defined as plasma alpha-tocopherol (alpha-T) below 300 microg/dL (<300E). Primary analyses evaluated CSI scores across the 4 levels of group (S or C) by using alpha-T status (<300E or >300E) with analysis of covariance.
RESULTS: After adjusting for covariates, CSI in the C<300E group was significantly lower than each of the other groups (C>300E, S<300E, and S>300E; P < .05). The highest proportion of CSI scores >84 occurred in the C<300E group (41%). Patients in this group also had the lowest mean head circumference z-scores at diagnosis.
CONCLUSIONS: Our results show that prolonged alpha-T deficiency in infancy is associated with lower subsequent cognitive performance. Thus, diagnosis via NBS may benefit the cognitive development of children with CF, particularly in those prone to vitamin E deficiency during infancy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16202783     DOI: 10.1016/j.jpeds.2005.08.003

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  14 in total

1.  A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis.

Authors:  Janelle Wells; Marjorie Rosenberg; Gary Hoffman; Michael Anstead; Philip M Farrell
Journal:  Pediatrics       Date:  2012-01-30       Impact factor: 7.124

Review 2.  Vitamin E supplementation in people with cystic fibrosis.

Authors:  Peter O Okebukola; Sonal Kansra; Joanne Barrett
Journal:  Cochrane Database Syst Rev       Date:  2017-03-06

3.  Molecular testing for cystic fibrosis carrier status practice guidelines: recommendations of the National Society of Genetic Counselors.

Authors:  Elinor Langfelder-Schwind; Barbara Karczeski; Michelle N Strecker; Joy Redman; Elaine A Sugarman; Christina Zaleski; Trisha Brown; Steven Keiles; Amy Powers; Sumheda Ghate; Rebecca Darrah
Journal:  J Genet Couns       Date:  2013-09-07       Impact factor: 2.537

4.  Extra corporeal membrane oxygenation (ECMO) therapy in a 3-year-old child with cystic fibrosis: a tale of hope.

Authors:  Patrick Stafler; Colin Wallis
Journal:  J R Soc Med       Date:  2009-07       Impact factor: 5.344

5.  Why bother to take vitamins?

Authors:  Alison Morton
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

6.  The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience.

Authors:  Scott D Grosse; John D Thompson; Yao Ding; Michael Glass
Journal:  Milbank Q       Date:  2016-06       Impact factor: 4.911

Review 7.  Vitamin E inadequacy in humans: causes and consequences.

Authors:  Maret G Traber
Journal:  Adv Nutr       Date:  2014-09       Impact factor: 8.701

Review 8.  Newborn screening for cystic fibrosis.

Authors:  Jack K Sharp; Michael J Rock
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

Review 9.  Recent advances in vitamin E metabolism and deficiency.

Authors:  Ephrem Eggermont
Journal:  Eur J Pediatr       Date:  2006-02-21       Impact factor: 3.183

10.  Standardization of Research-Quality Anthropometric Measurement of Infants and Implementation in a Multicenter Study.

Authors:  Christine Coburn-Miller; Susan Casey; Quynh Luong; Natalia Cameron; Jasna Hocevar-Trnka; Daniel H Leung; Daniel Gelfond; James E Heubi; Bonnie Ramsey; Drucy Borowitz
Journal:  Clin Transl Sci       Date:  2015-06-05       Impact factor: 4.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.